Clinimix 290 mg (l-Lysine (l-Lysine Hydrochloride) LIQUID) 290 MG

Clinimix 290 mg is a liquid intravenous solution containing L-Lysine Hydrochloride. It is used to provide essential amino acids for nutritional support in clinical settings. This product is manufactured by Baxter Corporation in Canada.

Strength

290 MG

Pack Size

1000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinimix 290 mg is primarily used for nutritional support in patients who require intravenous amino acid supplementation. It is often administered to individuals who cannot obtain adequate nutrition through oral intake. This solution helps to maintain or improve nutritional status in various clinical scenarios.

Side Effects

When administered intravenously, Clinimix 290 mg provides essential amino acids that support protein synthesis and overall nutritional health. The effects are typically observed as improved nutritional status and better clinical outcomes in patients requiring nutritional support.

Precautions & Warnings

Clinimix 290 mg should be administered under medical supervision. It is important to follow proper handling and storage guidelines to ensure the solution remains sterile and effective. Patients with known allergies to any of the components should avoid using this product.

Avoid Interactions

Clinimix 290 mg may interact with other medications or supplements. It is important to inform healthcare providers about all current medications to avoid potential interactions. Always consult a healthcare professional before starting any new treatment.

Frequently Asked Questions

Clinimix 290 mg is used for nutritional support in patients who require intravenous amino acid supplementation.

Clinimix 290 mg is administered intravenously under medical supervision.

The common effects include improved nutritional status and better clinical outcomes in patients requiring nutritional support.

Yes, it should be administered under medical supervision and proper handling and storage guidelines should be followed.

Yes, it may interact with other medications or supplements, so it is important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.